A Validation Study of Relationships Among Genomic Gene Expression Profile, Prognosis and Prediction of Adjuvant Chemotherapy Benefit With Capecitabine and Oxaliplatin in Gastric Cancer Stage II and III (6th AJCC) Patients After D2 Surgery (CLASSIC)
Clinical trial NCT03403296 · COMPLETED
Trial details
- NCT number
- NCT03403296
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-07-13
- Primary completion
- 2017-07-12
- Enrollment
- 640
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.